Priya Singhal Biogen Inc. (BIIB) insider trading activity

Priya Singhal is Head of Development of BIOGEN INC.. Currently has a direct ownership of 5,316 shares of BIIB, which is worth approximately $923,867. The most recent transaction as insider was on Sep 03, 2024, when has been sold 431 shares (Common Stock) at a price of $204.22 per share, resulting in proceeds of $88,018. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.32K

8.8% 3M change

58.5% 12M change

Total Value Held $923,867

Priya Singhal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Open market or private sale	$88,018 $204.22 p/Share	431 Reduced 7.5%	5,316 Common Stock
Aug 30 2024	SELL Payment of exercise price or tax liability	$165,241 $204.76 p/Share	807 Reduced 12.31%	5,747 Common Stock
Aug 30 2024	BUY Exercise of conversion of derivative security	-	1,668 Added 20.29%	6,554 Common Stock
Apr 02 2024	SELL Open market or private sale	$19,817 $213.09 p/Share	93 Reduced 1.87%	4,886 Common Stock
Feb 22 2024	SELL Open market or private sale	$57,962 $221.23 p/Share	262 Reduced 5.09%	4,886 Common Stock
Feb 16 2024	SELL Open market or private sale	$23,920 $221.49 p/Share	108 Reduced 2.05%	5,148 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$102,529 $219.08 p/Share	468 Reduced 8.18%	5,256 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	1,208 Added 18.2%	5,429 Common Stock
Feb 12 2024	SELL Open market or private sale	$100,329 $239.45 p/Share	419 Reduced 8.49%	4,516 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$90,126 $240.98 p/Share	374 Reduced 7.04%	4,935 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	-	1,212 Added 18.59%	5,309 Common Stock
Feb 02 2024	SELL Open market or private sale	$155,919 $245.93 p/Share	634 Reduced 13.4%	4,097 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$139,032 $247.83 p/Share	561 Reduced 10.6%	4,731 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	1,828 Added 25.67%	5,292 Common Stock
Dec 11 2023	SELL Open market or private sale	$27,280 $248.0 p/Share	110 Reduced 3.08%	3,464 Common Stock
Dec 08 2023	SELL Payment of exercise price or tax liability	$49,293 $239.29 p/Share	206 Reduced 5.45%	3,574 Common Stock
Dec 08 2023	BUY Exercise of conversion of derivative security	-	426 Added 10.13%	3,780 Common Stock
Sep 05 2023	SELL Open market or private sale	$116,124 $269.43 p/Share	431 Reduced 11.39%	3,354 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$215,606 $267.17 p/Share	807 Reduced 17.57%	3,785 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	1,668 Added 26.65%	4,592 Common Stock
Jul 03 2023	SELL Open market or private sale	$22,912 $282.87 p/Share	81 Reduced 2.7%	2,924 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$43,582 $284.85 p/Share	153 Reduced 4.84%	3,005 Common Stock
Jun 30 2023	BUY Exercise of conversion of derivative security	-	315 Added 9.07%	3,158 Common Stock
Apr 04 2023	SELL Open market or private sale	$25,217 $277.11 p/Share	91 Reduced 3.1%	2,843 Common Stock
Mar 28 2023	SELL Open market or private sale	$153,394 $270.06 p/Share	568 Reduced 16.66%	2,842 Common Stock

Priya Singhal

Head of Development

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Value

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOGEN INC.

Track Activities on BIIB

Account